Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. Legal: Bard loses 1st of transvaginal mesh patient injury lawsuits
A jury decides against C.R. Bard that the medical device company’s Avaulta Plus transvaginal mesh was responsible for injuries that a California woman suffered following surgery to treat pelvic organ prolapse.
6. Prostate cancer: Intuitive Surgical CEO Guthart on testing and “watchful waiting”
In this exclusive interview with MassDevice, Intuitive Surgical president & CEO Gary Guthart weighs in on shifts in the prostate surgery conversation and recent controversies over the benefits of testing and aggressive prostate cancer treatment.
5. J&J CEO Gorsky: BRIC countries want to change healthcare delivery
Johnson & Johnson’s Alex Gorsky, CEO of the world’s largest medical device company, tells investors that developing nations aren’t interested in "replicating what’s been done in the developed markets’ healthcare systems."
4. Funding: Who are the most active angel investors in healthcare?
If you’re a startup medical device company looking for an angel, it pays to go west, according to a new report.
3. Medical device tax: Abiomed’s Minogue takes to Capitol Hill to urge repeal
Abiomed chairman, president & CEO Mike Minogue testifies before the House of Representatives’ Committee on Small Business that the impending 2.3% medical device tax will pose an extra burden on small businesses that "need every dollar to survive."
2. Novation CEO Jody Hatcher: ‘Ruthlessly focused’ on driving hospital costs down
In an exclusive MassDevice.com interview, Novation CEO Jody Hatcher tells us what keeps hospital CEOs up at night.
1. Wall Street: Boston Scientific shares hit lowest level in nearly 20 years
Tough Q2 earnings reports and lowered 2012 forecasts push shares of medical device company Boston Scientific to the lowest level in 17 years.
